Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JL18008 in HIV Immunological Non-Responders
NCT07579741Phase 2Recruiting
- Sponsor
- Jecho Biopharmaceuticals Co., Ltd.
- Start
- May 2026
- Primary completion
- Feb 2027
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of JL18008 in human immunodeficiency virus infection (HIV), sponsored by Jecho Biopharmaceuticals Co., Ltd.. Started May 2026; status: recruiting.
02
Drugs
JL18008
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07579741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07579741.